Book cover for Pharmacology and the Nursing Process

Pharmacology and the Nursing Process

Linda Lane Lilley, Shelly Rainforth Collins, Julie S. Snyder

ISBN #9780323087896

7th Edition

394 Questions

Group icon
2,697 Students Helped

Homework Questions

Right arrow
Summary
Learning Objectives
Key Concepts
Example Problems
Explanations
Common Mistakes

Summary

Chapter 33 on Adrenal Drugs provides an in-depth overview of several key drug classes including alpha blockers, beta blockers, antiparkinson agents, and alkylating agents. The chapter focuses on the mechanisms of action, clinical indications, pharmacokinetic properties, and potential adverse effects associated with these medications. Special attention is given to proper dosage, administration routes, and contraindications, emphasizing the importance of patient-specific factors in ensuring effective and safe therapeutic outcomes.

Learning Objectives

1

Describe the mechanisms of action for alpha blockers, beta blockers, antiparkinson agents, and alkylating agents.

2

Identify the clinical indications for each drug class in the treatment of hypertension, BPH, Parkinson's disease, and cancer.

3

Explain the pharmacokinetic properties and potential adverse effects associated with these adrenal drugs.

4

Evaluate the importance of dosage, routes of administration, and contraindications to ensure safe therapeutic use.

5

Analyze how drug interactions and patient-specific factors influence the effectiveness of these medications.

Key Concepts

CONCEPT

DEFINITION

Alpha Blockers

Drugs that inhibit alpha-adrenergic receptors, leading to vasodilation and are primarily used in treating hypertension and benign prostatic hyperplasia (BPH).

Beta Blockers

Medications that block beta-adrenergic receptors, reducing heart rate and contractility, often used for controlling high blood pressure and managing cardiac conditions.

Antiparkinson Agents

A group of drugs used to manage symptoms of Parkinson's disease by either replenishing dopamine levels or mimicking its action in the brain.

Alkylating Agents

Chemotherapeutic agents that work by adding alkyl groups to DNA, thereby interfering with cancer cell replication and used in various cancers.

Pharmacokinetics

The study of how a drug is absorbed, distributed, metabolized, and excreted in the body.

Adverse Effects

Unintended and harmful effects that may occur with the use of a drug beyond its therapeutic effects.

Contraindications

Specific situations or conditions where a drug should not be used because it may be harmful to the patient.

Example Problems

Example 1

When monitoring for a therapeutic response to aminoglutethimide, the nurse will look for which potential outcomes? a Increase in Cushing's syndrome characteristics b Decrease in Cushing's syndrome characteristics c Increased lymphocyte levels d Growth suppression

Example 2

The nurse has provided teaching about oral corticosteroid therapy to a patient. Which statement by the patient shows a need for more teaching? a "I will report any fever or sore throat symptoms." b "I will stay away from anyone who has a cold or infection." c "I can stop this medication if I have severe adverse effects." d "I will take this drug with food or milk."

Example 3

During long-term corticosteroid therapy, the nurse will monitor the patient for Cushing's syndrome, which is manifested by a weight loss. b moon face. c hypotension. d thickened hair growth.

Example 4

When teaching a patient who has been prescribed a daily dose of prednisone (Deltasone), the nurse knows that the patient will be told to take the medication at which time of day to help reduce adrenal suppression? a In the morning b At lunchtime c At dinnertime d At bedtime

Example 5

Which teaching is appropriate for a patient who is taking an inhaled glucocorticoid for asthma? a "Exhale while pushing in on the canister of the inhaler." b "Blow your nose after taking the medication." c "Rinse your mouth thoroughly after taking the medication." d "Do not eat immediately after taking the medication."
Scroll left
Scroll right

Step-by-Step Explanations

QUESTION

How do alpha blockers exert their therapeutic effects in managing hypertension and BPH?

STEP-BY-STEP ANSWER:

Step 1: Recognize that alpha blockers bind to alpha-adrenergic receptors located on vascular smooth muscle and the prostate.
Step 2: Binding causes relaxation of smooth muscle, which reduces blood vessel resistance and alleviates high blood pressure.
Step 3: In the context of BPH, smooth muscle relaxation in the prostate and bladder neck diminishes urinary obstruction.
Final Answer: Alpha blockers work by relaxing smooth muscles in blood vessels and the urinary tract, thereby reducing blood pressure and improving urinary flow in BPH patients.

Alpha Blockers Mechanism

QUESTION

Explain the step-by-step process by which beta blockers help manage cardiovascular conditions.

STEP-BY-STEP ANSWER:

Step 1: Understand that beta blockers attach to beta-adrenergic receptors found in the heart and blood vessels.
Step 2: This binding leads to decreased heart rate and contractility, lowering the overall cardiac workload.
Step 3: Reduced demand on the heart lowers blood pressure and diminishes the risk of arrhythmias and other cardiac events.
Final Answer: Beta blockers help manage cardiovascular conditions by reducing heart rate and workload, thus lowering blood pressure and protecting against arrhythmic events.

Beta Blockers Mechanism

QUESTION

How do antiparkinson agents help alleviate the motor symptoms of Parkinson's disease?

STEP-BY-STEP ANSWER:

Step 1: Identify that many antiparkinson drugs either increase dopamine availability or mimic dopamine effects in the brain.
Step 2: Dopamine is critical in regulating movement, and its deficiency is a hallmark of Parkinson's disease.
Step 3: By enhancing dopaminergic activity, these agents reduce motor symptoms such as tremor, rigidity, and bradykinesia.
Final Answer: Antiparkinson agents alleviate motor symptoms by restoring dopaminergic function, either through dopamine supplementation or receptor stimulation.

Antiparkinson Agents Mechanism

QUESTION

Detail the mechanism by which alkylating agents function in cancer therapy.

STEP-BY-STEP ANSWER:

Step 1: Recognize that alkylating agents transfer alkyl groups to DNA molecules.
Step 2: This transfer results in DNA cross-linking or incorrect base pairing, interfering with DNA replication.
Step 3: The disruption of replication ultimately leads to cell death, particularly affecting rapidly dividing cancer cells.
Final Answer: Alkylating agents act by modifying DNA structure, thereby preventing proper cell replication and inducing cancer cell death.

Alkylating Agents Mechanism

Scroll left
Scroll right

Common Mistakes

  • Confusing the specific clinical indications for each drug class, such as using beta blockers for conditions best managed by alpha blockers.
  • Overlooking the potential adverse effects and drug interactions, thus underestimating the importance of monitoring and dosage adjustments.
  • Misunderstanding the pharmacokinetic properties which can lead to improper routes of administration or dosing intervals.
  • Assuming that all drugs in a particular class have identical mechanisms of action without considering the nuances in their pharmacodynamics.